Expressing support for designation of the month of April 2023 as "Parkinson's Awareness Month".
Impact
The adoption of HR347 serves as a call to action for lawmakers and the public alike to focus on the challenges faced by Parkinson's patients and their families. It underscores the urgency in investing in research for better treatments and ultimately a cure. The economic implications could be substantial, with projections indicating the cost of Parkinson’s disease may exceed $80 billion annually in just a few years.
Summary
HR347 is a resolution expressing support for the designation of April 2023 as 'Parkinson's Awareness Month.' The bill emphasizes the significance of raising awareness about Parkinson's disease, which affects over a million individuals in the U.S. and is a leading cause of death. The resolution highlights the need for increased research and community support services aimed at improving the quality of life for those living with the disease.
Contention
While the resolution is largely supportive and framed positively, there are underlying tensions concerning the allocation of resources for Parkinson's research versus other health priorities. Advocates for various health issues may raise concerns over equitable attention and funding. The resolution aims to bridge such divides by uniting various stakeholders around a common goal of improving lives affected by Parkinson's.